Do Wall Street Analysts Like Invesco Stock?
/Invesco%20Ltd%20billboard-by%20Poetra_RH%20via%20Shutterstock.jpg)
Atlanta-based Invesco Ltd. (IVZ) is a global investment management company dedicated to helping clients achieve their financial goals. With a market cap of $6.4 billion, the firm offers a diverse range of investment solutions, including mutual funds, ETFs, and private funds, catering to retail, institutional, and high-net-worth clients worldwide.
The asset manager has significantly underperformed the broader market over the past year. IVZ stock has plunged 18.9% on a YTD basis and 5.2% over the past 52 weeks, compared to the S&P 500 Index’s ($SPX) 4.7% dip in 2025 and 8.2% gains over the past year.
Zooming in further, Invesco has also underperformed the Financial Select Sector SPDR Fund’s (XLF) 1.7% uptick on a YTD basis and 19.7% surge over the past year.
Invesco’s stock prices soared 8.3% after the release of its better-than-expected Q1 results on Apr. 22. The company’s net flows for the quarter stood at $32.6 billion, significantly down from $60.9 billion in Q4 2024, but represent a staggering 97.6% increase from the year-ago quarter. Meanwhile, its total operating revenues increased 3.7% year-over-year to $1.5 billion, and the company observed a notable expansion in margins. Its adjusted net income for the quarter soared 35.1% year-over-year to $200.5 million, and its adjusted EPS of $0.44 surpassed the consensus estimates by 12.8%.
For the full fiscal 2025, ending in December, analysts expect the asset manager to report a 1.8% year-over-year decline in adjusted EPS to $1.68. However, the company has a solid earnings surprise history. It has met or surpassed the Street’s bottom-line estimates in each of the past four quarters.
Invesco has a consensus “Hold” rating overall. Of the 18 analysts covering the stock, opinions include one “Strong Buy,” 16 “Holds,” and one “Strong Sell.”
This configuration is slightly bearish compared to a month ago, when two analysts gave “Strong Buy” recommendations.
On Apr. 23, Evercore ISI analyst Glenn Schorr maintained an “In-Line” rating on IVZ, while raising the price target from $13 to $15.
Invesco’s mean price target of $15.98 represents a premium of 12.7% to current price levels, while its street-high target of $21 suggests a 48.1% potential upside.
On the date of publication, Aditya Sarawgi did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.